“Experts find new targets to stop breast cancer” (Reuters)
“Senate Democrats impatient with healthcare pace” (Reuters)
“Growth Factor Eye Drops May Provide Neuroprotection for Glaucoma” (Elsevier Global Medical News)
“Germany Gets Creative with Payer-Pharmaco Contracts” (The Pink Sheet)
“AHRQ, NIH Report To Congress On Comparative Effectiveness Funding” (The Gray Sheet)
“FDA Requests Seizure Of All Clarcon Sanitizers Following Recall” (The Tan Sheet)
“Teva, Perrigo get FDA nod for allergy nasal spray” (Teva Pharmaceutical Industries Ltd.)
“Ferring Pharmaceuticals Announces Trade Name Firmagon for Advanced Prostate Cancer Treatment” (Ferring Pharmaceuticals)
“AstraZeneca/Bristol’s Onglyza Gains Approval, But Now Has To Face Januvia” (The Pink Sheet)
“GSK Denosumab Deal Gives Amgen A Leg Up In Primary Care” (The Pink Sheet)
“Plavix Pharmacogenomic Label Update May Help Lilly with Effient Launch” (The Pink Sheet)
“Number of Americans taking antidepressants doubles” (USA Today)
“New HIV strain discovered in woman from Cameroon” (USA Today)
“House Panel Approves Sweeping Health Bill” (Wall Street Journal)
“Sanofi-aventis U.S. Introduces BenzaClin Carekit” (Reuters)
“Obama enjoys workd’s best health care” (Chicago Tribune)
“Leading Boston Dermatologist Performs Live Artefill Patient Demonstration at American Academy of Dermatology Summer Meeting” (PR Newswire)
“Overheard: Drug Industry Megamergers” (Wall Street Journal)
SUBSCRIBE